UPDATE: Solazyme Downgraded by Goldman Sachs on Short-Term Valuation

By: via Benzinga
Goldman Sachs analyst Brian Lee downgraded Solazyme (NASDAQ: SZYM) Tuesday morning, lowering rating from Buy to Neutral and a price ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.